Corient Private Wealth’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.97M Buy
57,048
+108
+0.2% +$13.7K 0.01% 722
2026
Q1
$6.13M Buy
56,940
+25,962
+84% +$2.92M 0.01% 782
2025
Q4
$3.5M Buy
30,978
+28,160
+999% +$2.69M ﹤0.01% 901
2025
Q3
$230K Sell
2,818
-28,781
-91% -$2.64M ﹤0.01% 2286
2025
Q2
$3.26M Buy
31,599
+1,702
+6% +$160K ﹤0.01% 842
2025
Q1
$2.94M Sell
29,897
-344
-1% -$45.9K ﹤0.01% 844
2024
Q4
$4.53M Buy
30,241
+341
+1% +$47K 0.01% 731
2024
Q3
$3.9M Buy
29,900
+5,112
+21% +$636K 0.01% 827
2024
Q2
$2.93M Sell
24,788
-135
-0.5% -$14.3K 0.01% 880
2024
Q1
$2.35M Buy
24,923
+148
+0.6% +$13.2K ﹤0.01% 954
2023
Q4
$1.97M Buy
24,775
+163
+0.7% +$11.1K ﹤0.01% 1008
2023
Q3
$1.85M Buy
24,612
+6,122
+33% +$457K ﹤0.01% 945
2023
Q2
$1.32M Buy
18,490
+26
+0.1% +$1.49K ﹤0.01% 1057
2023
Q1
$925K Buy
18,464
+1,966
+12% +$95.4K ﹤0.01% 1115
2022
Q4
$721K Buy
+16,498
New +$814K ﹤0.01% 1024

Other funds holding GKOS

Corient Private Wealth's GKOS Position: Q2 2026 in Review

Corient Private Wealth increased its Glaukos (GKOS) stake by 0.19% in Q2 2026, buying an estimated $13.7K and bringing the position to 57,048 shares worth $7.97M. The position accounts for 0.01% of the portfolio, ranked #722.

Corient Private Wealth first reported a position in GKOS in Q4 2022 and has held it in 15 quarters since. 365 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Corient Private Wealth held 57,048 shares of Glaukos worth $7.97M as of Q2 2026.
  • Corient Private Wealth bought 108 Glaukos shares in Q2 2026, an estimated $13.7K.
  • Glaukos made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #722 holding.
  • Corient Private Wealth first reported a position in Glaukos in Q4 2022 and has held it in 15 quarters since.
  • 365 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.